Cargando…
Recombinant expression of Streptococcus pneumoniae capsular polysaccharides in Escherichia coli
Currently, Streptococcus pneumoniae is responsible for over 14 million cases of pneumonia worldwide annually, and over 1 million deaths, the majority of them children. The major determinant for pathogenesis is a polysaccharide capsule that is variable and is used to distinguish strains based on thei...
Autores principales: | Kay, Emily J., Yates, Laura E., Terra, Vanessa S., Cuccui, Jon, Wren, Brendan W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838161/ https://www.ncbi.nlm.nih.gov/pubmed/27110302 http://dx.doi.org/10.1098/rsob.150243 |
Ejemplares similares
-
Recent advances in the production of recombinant glycoconjugate vaccines
por: Kay, Emily, et al.
Publicado: (2019) -
Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccines
por: Kay, Emily J., et al.
Publicado: (2022) -
Synthesis and delivery of Streptococcus pneumoniae capsular polysaccharides by recombinant attenuated Salmonella vaccines
por: Su, Huali, et al.
Publicado: (2021) -
Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine
por: Herbert, Jenny A., et al.
Publicado: (2018) -
PglB function and glycosylation efficiency is temperature dependent when the pgl locus is integrated in the Escherichia coli chromosome
por: Terra, Vanessa S., et al.
Publicado: (2022)